An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This observational study is conducted in Europe. The aim of this observational study is to investigate the changes in a score (GET-score) which includes quality of life, body composition and cholesterol metabolism in patients on growth hormone treatment. The GET score stands for: Growth hormone deficiency and Efficacy of Treatment, and is a quantitative measurement of the efficacy of the treatment with growth hormone in adults.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S

Criteria

Inclusion Criteria:

• Severe acquired growth hormone deficiency

• No treatment with somatropin in the last 24 months before study participation

• Written informed consent

Exclusion Criteria:

• Contraindications for the treatment with somatropin